QUANTRX BIOMEDICAL CORPORATION
CIK 0000820608
Revenue (TTM)
$0
Q3 Nov 2022
Net Income (TTM)
−$262.48K
−2.9% YoY
Q3 Nov 2022
EPS Diluted (TTM)
—
Q3 Nov 2022
Gross Margin
—
Q3 Nov 2022
Operating Margin
—
Q3 Nov 2022
Net Margin
—
Q3 Nov 2022
Free Cash Flow (TTM)
—
Q3 Nov 2022
Cash
$3.88K
Q3 Nov 2022
Total Debt
$38.69K
Q3 Nov 2022
Shares Outstanding
78.7M sh
Q3 Nov 2022
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.